Virology. Dulbecco et al. pp. 77-79, 1988.* |
The Microbes. Vandermark et al. pp. 670-680, 1986.* |
Aoki K et al., “Differential sensitivity of two related viruses, Newcastle disease virus and Sendai virus, to interferon in mouse Had-2 cells selective inhibition of translation of NDV mRNA.”, Arch Virol. 1996;141(10):1847-62. |
Baez M et al., “Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains”, Nucleic Acids Res. Dec. 11, 1980:8(23):5845-58. |
Beatrice et al., “Immunogenicity in mice of temperature-sensitive mutants of vesicular stomatitis virus: early appearance in bronchial secretions of an interferon-like inhibitor”, J Gen Virol. 1980; 47:529-533. |
Belardelli F and Gresser I, “The neglected role of type I interferon in the T-cell response: implications for its clinical use”, Immunol Today. Aug. 1996;17(8):369-72. |
Buonagurio DA et al., “Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene”, Science. May 23, 1986;232(4753):980-2. |
Butterfield et al., “Vaccination for fowl plague”, Am J Vet Res. Apr. 1978; 39(4):671-674. |
Chen Z et al., “Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery”, EMBO J. Apr. 15, 1999;18(8):2273-83. |
Crowe JE, “Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines”, Vaccine. Aug. 1998; 16(14/15):1423-1432. |
de la Luna S et al., “Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs”, J Virol. Apr. 1995;69(4):2427-33. |
Desmyter J et al., “Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero)”, J Virol. Oct. 1968;2(10):955-61. |
Diaz Mo et al., “Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines”, Proc Natl Acad Sci U S A. Jul. 1988;85(14):5259-63. |
Durbin JE et al., “Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease”, Cell. Feb. 9, 1996;84(3):443-50. |
Egorov A et al., “Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells”, J Virol. Aug. 1998;72(8):6437-41. |
Egorov AY et al., “Generation of influenza A transfectant viruses containing deletions of the carboxyl-terminal part of the NS1 protein”, in Emergence and Re-emergence of Negative Strand Viruses, Tenth International Conference on Negative Strand Viruses. 1997, Dublin, Ireland. Abstract No. 108, p. 104. |
Egorov Alu et al., “[The NS gene—a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]”, Vopr Virusol. Sep.-Oct. 1994;39(5):201-5. Russian. |
Enami M and Palese P, “High-efficiency formation of influenza virus transfectants”, J Virol. May 1991;65(5):2711-3. |
Enami M et al., “An influenza virus containing nine different RNA segments”, Virology. Nov. 1991;185(1):291-8. |
Enami K et al., “Influenza virus NS1 protein stimulates translation of the M1 protein”, J Virol. Mar. 1994;68(3):1432-7. |
Fodor E et al., “Attenuation of influenza A virus mRNA levels by promoter mutations”, J Virol. Aug. 1998;72(8):6283-90. |
Fortes P et al., “Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport”, EMBO J. Feb. 1, 1994;13(3):704-12. |
Garcia-Sastre A et al., “Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems”, Virology. Dec. 20, 1998;252(2):324-30. |
Garcia-Sastre A et al., “The role of interferon in influenza virus tissue tropism”, J Virol. Nov. 1998;72(11):8550-8. |
Goodpasture et al. “The cultivation of vaccine and other viruses in the chorioallantoic membrane of chick embryos”, Science. 1934; 74(1919):371-372. |
Haller O et al., “Genetic resistance to influenza virus in wild mice”, Curr Top Microbiol Immunol. 1986;127:331-7. |
Haller O et al., “Host gene influences sensitivity to interferon action selectively for influenza virus”, Nature. Feb. 14, 1980;283(5748):660-2. |
Haller O., “Inborn resistance of ice to orthomyxoviruses”, Curr Top Microbiol Immunol. 1981;92:25-52. |
Hatada E et al., “Binding of influenza A virus NS1 protein to dsRNA in vitro”, J Gen Virol. Dec. 1992;73 (Pt 12):3325-9. |
Krug and Soeiro, 1975, “Studies on the intranuclear localization of influenza virus-specific proteins”, Virology 64: 378-87. |
Krug, 1995, “Chapter 8. Unique Functions of the NS1 Protein” in Textbook of Influenza, Nicholson et al. (eds.), pp. 82-92. |
Li X and Palese P, “Characterization of the polyadenylation signal of influenza virus RNA”, J Virol. Feb. 1994;68(2):1245-9. |
Li X and Palese P, “Mutational analysis of the promoter required for influenza virus virion RNA synthesis”, J Virol. Jul. 1992;66(7):4331-8. |
Lu Y et al., “The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing”, Genes Dev. Aug. 1, 1994;8(15):1817-28. |
Lu Y et al., “Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor”, Virology. Dec. 1, 1995;214(1):222-8. |
Luo GX et al., “The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure”, J Virol. Jun. 1991;65(6):2861-7. |
Luytjes W et al., “Amplification, expression, and packaging of foreign gene by influenza virus”, Cell. Dec. 22, 1989;59(6):1107-13. |
Marion RM et al., “The N-terminal half of influenza virus NS1 protein is fully active both in mRNA nuclear retention and enhancement of translation”, in Emergence and Re-emergence of Negative Strand Viruses, Tenth International Conference on Negative Strand Viruses. 1997, Dublin, Ireland. Abstract No. 240, p. 170. |
Marion RM et al., “The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation”, Nucleic Acids Res. Nov. 1, 1997;25(21):4271-7. |
Meraz MA et al., “Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway”, Cell. Feb. 9, 1996;84(3):431-42. |
Mosca JD et al., “Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis”, Mol Cell Biol. Jun. 1986;6(6):2279-83. |
Murphy B.R. and R.G. Webster, 1996, “Orthomyxoviruses” in Fields Virology, Lippincott-Raven P.A., pp. 1397-1445. |
Muster T et al., “An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice”, Proc Natl Acad Sci U S A. Jun. 15, 1991;88(12):5177-81. |
Nemeroff ME et al., “Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs”, Mol Cell. Jun. 1998;1(7):991-1000. |
Nemeroff ME et al., “Unique interactions of the influenza virus NS 1 protein with host cell nuclear functions”, in Emergence and Re-emergence of Negative Strand Viruses, Tenth International Conference on Negative Strand Viruses. 1997, Dublin, Ireland. Abstract No. 229, p. 164. |
Norton GP et al., “Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides”, Virology. Feb. 1987;156(2):204-13. |
Park YW and Katze MG, “Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation”, J Biol Chem. Nov. 24, 1995;270(47):28433-9. |
Parvin JD et al., “Nonsense mutations affecting the lengths of the NS1 nonstructural proteins of influenza A virus isolates”, Virology. Jul. 30, 1983;128(2):512-7. |
Perry MM and Sang HM, “Transgenesis in chickens”, Transgenic Res. May 1993;2(3):125-33. |
Piccone ME et al., “Mutational analysis of the influenza virus vRNA promoter”, Virus Res. May 1993;28(2):99-112. |
Pleschka S et al., “A plasmid-based reverse genetics system for influenza A virus”, J Virol. Jun. 1996; 70(6):4188-92. |
Qin XQ et al., “Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice”, Proc Natl Acad Sci U S A. Nov. 24. 1998; 95(24):14411-6. |
Qiu Y and Krug RM, “The influenza virus NS1 protein is a poly(A)-binding protein that inhibits and nuclear export of mRNAs containing poly(A)”, J Virol. Apr. 1994;68(4):2425-32. |
Qiu Y et al., “The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing”, RNA. May 1995;1(3):304-16. |
Sang H., “Transgenic chickens—methods and potential applications”, Trends Biotechnol. Oct. 1994;12(10):415-20. |
Sekellick MJ et al., “Interferon induction by viruses. XIV. Development of interferon inducibility and its inhibition in chick embryo cells “aged” in vitro”, J Interferon Res. 1985 Fall;5(4):651-67. |
Sekellick MJ et al., “Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro”, In Vitro Cell Dev Biol. Oct. 1990;26(10):997-1003. |
Shaw et al., 1996, “Nucleocapsid protein alone is sufficient for the generation of influenza transfectants” in Options for the Control of Influenza III, Brown(eds.), Hampson Webster (Elsevier Science) pp. 433-436. |
Shuman RM., “Production of Transgenic birds”, Experientia. Sep. 15, 1991;47(9):897-905. |
Stern CD., “Chick stem cells”, Curr Top Microbiol Immunol. 1996;212:195-206. |
Tobita K et al., “Nucleotide sequence and some biological properties of the NS gene of a newly isolated influenza B virus mutant which has a long carboxyl terminal deletion in the NS1 protein”, Virology. Jan. 1990;174(1):314-9. |
Weaver BK et al., “Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1”, Mol Cell Biol. Mar. 1998;18(3):1359-68. |
Chang et al., 1992, “The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, doulbe-stranded RNA-dependent protein kinase”, Proc. Natl. Acad. Sci USA 89:4825-4829. |
Cossins et al., 1993, “Precise Predicitionof a Kk Restricted Cytotoxic T Cell Epotope in the NS1 Protein of Influenza Virus Using an NHC Allele Specific Motif”, Virology, 193:289-295. |
Hackett et al., 1992, “Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non structural protein”, J. of Gen. Virology 73:1339-1343. |
Katinger et al., 1997, “Attenuated Influenza Virus as a Vector for Mucosal Immunization Against HIV-1”, Vaccine 315-319. |
Kuwano et al., 1990, “Cross reactive protection against influenza A virus infections by an NS1-specific CTL clone”, Immunochemistry 113:499. |
Kuwano et al., 1988, “HA2 Subunit of Influenza A H1 and H2 Subtype Viruses Induces a Protective Cross Reactive Cytotoxic T Lymphocyte Response”, J. Immunol., 140:1264-1268. |
Maassab and DeBorde, 1983, “Characterization of an Influenza A Host Range Mutant”, Virology 130:342-350. |
Shaw et al., 1982, “Immunologic Studies on the Influenza A Virus Nonstructural Protein NS”, J. Exp. Med., 156:243-254. |
Snyder et al., 1990, “A 36 Nucleotide Deletion Mutation in the Coding Region of the SN1 Gene of an Influenza A Virus RNA Segment 8 Specifies a Temperature-Dependent Host Range Phenotype”, Virus Research 15:69-84. |
Yoshida et al., 1981, “Characterization of the RNA Associated with Influenza A Cytoplasmic Inclusions and the Interaction of NS1 Protein with RNA”, Virology 110:87-97. |
Young et al., 1983, “Efficient Expression of Influenza Virus NS1”, Proc. Natl. Acad. Sci. 80:6'05-6109. |
Ferner et al. 1974. The Biology of Animal Viruses 2nd Ed. New York: Academic Press. 42-43. |
Maramorosh, K and Koprowski, H. 1967. Methods in Virology vol. 1. Ch. 6. New York: Academic Press. 178-216. |
Yannarell DA, Hjorth RN. Factors affecting the yield of cold-adapted influenza virus vaccine. J Virol Methods. 64(2):161-9. |